Suppr超能文献

HMGB1 表达评估胃癌严重程度的价值:系统荟萃分析。

Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis.

机构信息

Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.

Department of Gastrointestinal Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.

出版信息

J Int Med Res. 2021 Mar;49(3):300060521993312. doi: 10.1177/0300060521993312.

Abstract

OBJECTIVE

To evaluate the clinical value of high mobility group box-1 (HMGB1) expression levels in patients with gastric cancer.

METHODS

Articles published from January 2000 to August 2022 were searched using PubMed, Google Scholar and Science Direct, Springer, Wiley and NIH to evaluate the clinicopathological significance of HMGB1 expression in gastric cancer.

RESULTS

A total of 156 publications were selected, of which six studies, comprising 846 patients, met the criteria for inclusion in this study. Forest plots of clinicopathological characteristics indicated that HMGB1 expression was not associated with age (odds ratio (OR) = 1.07, 95% confidence interval (CI): 0.89-1.28), sex (OR = 0.90, 95% CI: 0.81-1.00), TNM (OR = 1.39, 95% CI: 0.82-2.37), N stage (OR = 1.42, 95% CI: 0.97-2.07), or tumor differentiation (OR = 0.96, 95% CI: 0.71-1.29), but was highly correlated with pT stage (OR = 1.56, 95% CI: 1.17-2.07). Funnel plots showed no significant publication bias in the included studies in terms of age, sex, TNM, pT stage, N stage, or tumor differentiation.

CONCLUSION

HMGB1 expression was significantly correlated with tumor pT stage, but not with age, sex, TNM stage, tumor N stage, tumor differentiation, or lymphatic metastasis in patients with GC.

摘要

目的

评估高迁移率族蛋白 B1(HMGB1)在胃癌患者中的表达水平的临床价值。

方法

通过检索 PubMed、Google Scholar 和 Science Direct、Springer、Wiley 和 NIH,检索 2000 年 1 月至 2022 年 8 月发表的文章,以评估 HMGB1 在胃癌中的表达与临床病理特征的相关性。

结果

共筛选出 156 篇文献,其中 6 项研究(共 846 例患者)符合纳入标准。临床病理特征的森林图表明,HMGB1 的表达与年龄(比值比(OR)=1.07,95%置信区间(CI):0.89-1.28)、性别(OR=0.90,95%CI:0.81-1.00)、TNM(OR=1.39,95%CI:0.82-2.37)、N 分期(OR=1.42,95%CI:0.97-2.07)或肿瘤分化(OR=0.96,95%CI:0.71-1.29)无关,但与 pT 分期(OR=1.56,95%CI:1.17-2.07)高度相关。漏斗图显示,纳入的研究在年龄、性别、TNM、pT 分期、N 分期或肿瘤分化方面均无显著发表偏倚。

结论

HMGB1 的表达与 GC 患者的肿瘤 pT 分期显著相关,但与年龄、性别、TNM 分期、肿瘤 N 分期、肿瘤分化或淋巴转移无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc8/7944546/33f148cc4966/10.1177_0300060521993312-fig1.jpg

相似文献

1
Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis.
J Int Med Res. 2021 Mar;49(3):300060521993312. doi: 10.1177/0300060521993312.
6
Clinicopathological Significance of Neuropilin 1 Expression in Gastric Cancer: A Meta-Analysis.
Dis Markers. 2020 Sep 19;2020:4763492. doi: 10.1155/2020/4763492. eCollection 2020.
7
The clinical significance of snail protein expression in gastric cancer: a meta-analysis.
Hum Genomics. 2016 Jul 25;10 Suppl 2(Suppl 2):22. doi: 10.1186/s40246-016-0070-6.

引用本文的文献

1
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer.
World J Gastroenterol. 2023 Feb 14;29(6):997-1010. doi: 10.3748/wjg.v29.i6.997.

本文引用的文献

1
Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer.
Cancer Manag Res. 2020 Jan 8;12:117-126. doi: 10.2147/CMAR.S207934. eCollection 2020.
2
Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.
J Cell Physiol. 2020 Apr;235(4):3438-3446. doi: 10.1002/jcp.29233. Epub 2019 Oct 16.
3
Epidemiology of gastric cancer: global trends, risk factors and prevention.
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.
4
HMGB1 protein as a novel target for cancer.
Toxicol Rep. 2019 Mar 2;6:253-261. doi: 10.1016/j.toxrep.2019.03.002. eCollection 2019.
5
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis.
Immunity. 2018 Oct 16;49(4):740-753.e7. doi: 10.1016/j.immuni.2018.08.016. Epub 2018 Oct 9.
7
Extracellular HMGB1 as a therapeutic target in inflammatory diseases.
Expert Opin Ther Targets. 2018 Mar;22(3):263-277. doi: 10.1080/14728222.2018.1439924. Epub 2018 Feb 15.
8
Gastric cancer: epidemiology, prevention, classification, and treatment.
Cancer Manag Res. 2018 Feb 7;10:239-248. doi: 10.2147/CMAR.S149619. eCollection 2018.
9
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
Cell Res. 2017 Jul;27(7):916-932. doi: 10.1038/cr.2017.51. Epub 2017 Apr 4.
10
Emerging roles for HMGB1 protein in immunity, inflammation, and cancer.
Immunotargets Ther. 2015 May 26;4:101-9. doi: 10.2147/ITT.S58064. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验